Keywords: tkt, replagal, cleared, canada, usa-based, transkaryotic, therapies

TKT's Replagal cleared in Canada

Article | 16 February 2004

USA-based Transkaryotic Therapies has been granted regulatory approval from Health Canada to market its Replagal (agalsidase alfa), an enzyme replacement ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Genzyme

Go to company listing

Related Drugs

Agalsidase Beta

Fabrazyme

Go to drug listing